A clinical trial study of a traditional Chinese medicine prescription combined with balance acupuncture in the treatment of migraine

Not Applicable

• Conditions: migraine

• Registration Number: ITMCTR2100005174
• Lead Sponsor: Affiliated Hospital of Changchun University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1.Meet the diagnostic criteria of Western medicine for migraine (migraine with aura or migraine without aura);
2.Patients who meet the diagnostic criteria of liver-yang hyperactivity syndrome based on TCM differentiation;
3.4 points <= VAS score <= 8 points, which affects work and study;
4.For 3 months, the number of headache attacks every 4 weeks without aura migraine is more than 5 times (including 5 times); migraine with aura is more than 2 times (including 2 times);
5.The age is between 18 and 65 years old; the age of first onset is =50 years old;
6.The patient gave informed consent and signed the informed consent form.

Exclusion Criteria

1.Headache, but as a symptom of other diseases, such as hypertensive headache, cerebral hemorrhage brain disease, post-traumatic headache, intracranial low pressure headache, headache caused by intracranial space-occupying lesions, and ENT eye , Ear, nose, and paranasal sinus disease accompanied by headache, poisoning, febrile and other headaches;
2.Special types of migraine, such as ophthalmoplegia, hemiplegic migraine, basilar artery migraine, etc.;
3.Other types of headaches such as tension-type headaches, cluster headaches and neurotic headaches;
4.Those who take painkillers or who are dependent on painkillers during the trial period;
5.Take medicines that may have the effect of preventing and curing headache attacks (such as sibilene, nimodipine, etc.) for 3 months;
6.Patients with severe cardiopulmonary insufficiency, severe primary diseases such as liver, kidney, hematopoietic system, mental illness, gastrointestinal diseases that seriously affect drug absorption;
7.Patients who have used antipsychotics or antidepressants 3 months before the test;
8.Suspected or true history of alcohol or drug abuse, or other diseases or conditions that reduce the possibility of enrollment or complicate enrollment according to the judgment of the investigator, such as frequent changes in the working environment and cause loss to follow-up.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Headache measure;